PREVENTION OF Β THALASSEMIA IN NORTHERN ISRAEL - A COST-BENEFIT ANALYSIS.
Background:β Thalassemia major is characterized by hemolytic anemia, ineffectiveerythropoiesis and hemosiderosis. About 4 % of the world population carries a Thalassemiagene. Management includes blood transfusions and iron chelation, this treatmentis costly and population screening may be significan...
Main Authors: | Ariel Koren, Lora Profeta, Luci Zalman, Haya Palmor, Carina Levin, Ronit Bril Zamir, Stavit Shalev, Orna Blondheim |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2014-02-01
|
Series: | Mediterranean Journal of Hematology and Infectious Diseases |
Subjects: | |
Online Access: | http://www.mjhid.org/index.php/mjhid/article/view/1382 |
Similar Items
-
DETECTION OF Β THALASSEMIA CARRIERS BY RED CELL PARAMETERS OBTAINED FROM AUTOMATIC COUNTERS USING MATHEMATICAL FORMULAS
by: Idit Lachover Roth, et al.
Published: (2018-01-01) -
Extracellular Vesicle Characteristics in β-thalassemia as Potential Biomarkers for Spleen Functional Status and Ineffective Erythropoiesis
by: Carina Levin, et al.
Published: (2018-08-01) -
THE PRICE OF MERCY: COMMENT TO THE PAPER "PREVENTION OF BETA-THALASSEMIA IN NORTHERN ISRAEL - A COST-BENEFIT ANALYSIS” BY KOREN ET AL
by: Eliezer Rachmilewitz
Published: (2014-03-01) -
Thalassemia: An overview
by: Ramesh Aggarwal, et al.
Published: (2014-01-01) -
REVIEW AND RECOMMENDATIONS ON MANAGEMENT OF ADULT FEMALE THALASSEMIA PATIEΝTS WITH HYPOGONADISM BASED ON LITERATURE REVIEW AND EXPERIENCE OF ICET-A NETWORK SPECIALISTS
by: Vincenzo De Sanctis
Published: (2017-01-01)